喹啉-8-甲醛 | 38707-70-9

• 物质功能分类: 有机原料 - 醛类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 喹啉-8-甲醛
• 中文别名: 8-甲酰基喹啉；8-喹啉甲醛
• 英文名称: 8-formylquinoline
• 英文别名: quinoline-8-carbaldehyde；quinoline-8-carboxaldehyde；8-quinolinecarbaldehyde；8-quinolinecarboxaldehyde；quinoline-8-formaldehyde
• CAS: 38707-70-9
• 化学式: C₁₀H₇NO
• mdl: MFCD00805837
• 分子量: 157.172
• InChiKey: OVZQVGZERAFSPI-UHFFFAOYSA-N

物化性质

• 熔点：
  95-96°C
• 沸点：
  314.3±15.0 °C(Predicted)
• 密度：
  1.223±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  常规情况下不会分解，没有危险反应。

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933499090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  密封、阴凉、干燥保存。

SDS

Name:	8-Quinolinecarbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS:	38707-70-9

Section 1 - Chemical Product MSDS Name:8-Quinolinecarbaldehyde 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
38707-70-9	8-Quinolinecarbaldehyde	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 38707-70-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: cream
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 96 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H7NO
Molecular Weight: 157.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 38707-70-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
8-Quinolinecarbaldehyde - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 38707-70-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 38707-70-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 38707-70-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  喹啉-8-甲醛 在 钯 作用下， 以 硫酸 为溶剂， 反应 1.5h， 生成 1-(8-quinolinyl)-β-carboline
  参考文献：
  名称：

  Nitraria komarovii 的生物碱。五、科马罗霉素的结构与合成

  摘要：

  新的生物碱 komarovicine 已从植物 Nitraria komarovii Iljin et Lava 的表生部分分离出来。其结构已根据光谱和实验结果确定，并已进行合成。已经过渡到先前分离的生物碱 komarovine 和 komarovidine。

  DOI：

  10.1007/bf00575048
• 作为产物：
  描述：

  8-溴甲基喹啉 在 三乙胺 作用下， 以 乙二醇二甲醚 为溶剂， 反应 4.0h， 生成 喹啉-8-甲醛
  参考文献：
  名称：

  一种将芳香族甲基直接氧化成醛和羧酸的简便方法

  摘要：

  连接到芳环上的甲基氧化生成醛和/或羧酸，是有机化学中的常见反应。获得酸的经典方法是用强氧化剂直接氧化，并已在许多条件下进行。l 但是有局限性，我们对连接到多环杂环上的甲基的经验是，环系统的大量分解伴随着靶向氧化。在转化为醛的各种间接方法中，下面显示的先前报道的 Z 序列具有吸引人的特征。ACHJ ArCHZBr ArCH20N& ACHO

  DOI：

  10.1080/00304940309355366
• 作为试剂：
  描述：

  仲丁胺 、 di([1,1'-biphenyl]-4-yl)iodonium tetrafluoroborate 、 苯甲酸酐 在 喹啉-8-甲醛 、 2,6-二叔丁基-4-甲基吡啶 、 Pd(opiv)2 、 甲氧基胺盐酸盐 、 三乙胺 作用下， 以 1,2-二氯乙烷 、 二氯甲烷 为溶剂， 反应 62.0h， 以69%的产率得到N-(4-([1,1'-biphenyl]-4-yl)butan-2-yl)benzamide
  参考文献：
  名称：

  带有原位生成的exo导向基团的游离伯胺的催化C（sp3）-H芳基化

  摘要：

  在这里，我们报告了游离伯胺中未活化的脂肪族CH键的钯催化直接芳基化。该方法利用了可在原位生成和去除的外亚胺型导向基团（DG）。一系列未保护的脂族胺是合适的底物，在γ位置进行位点选择性芳基化。甲基以及环状和无环亚甲基均可被活化。此外，当使用苯胺衍生的底物时，通过δ-CHH芳基化获得了初步的成功。还证明了以催化方式使用DG组分的可行性。

  DOI：

  10.1002/anie.201604268

文献信息

• [EN] 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY<br/>[FR] 2,4-DIAMINOQUINAZOLINES UTILES POUR LE TRAITEMENT D'UNE ATROPHIE MUSCULAIRE SPINALE
  申请人：DECODE CHEMISTRY INC

  公开号：WO2005123724A1

  公开（公告）日：2005-12-29

  2,4-Diaminoquinazolines of formulae I-IV and VI (I, II, III, IV and VI) are useful for treating spinal muscular atrophy (SMA).

  2,4-二氨基喹唑啉的化学式I-IV和VI（I，II，III，IV和VI）可用于治疗脊髓性肌萎缩症（SMA）。
• Rhodium-Catalyzed Synthesis of Amides from Aldehydes and Azides by Chelation-Assisted CH Bond Activation
  作者：Bing Zhou、Yaxi Yang、Jingjing Shi、Huijin Feng、Yuanchao Li

  DOI：10.1002/chem.201301168

  日期：2013.8.5

  CH activation: A RhIII‐catalyzed direct aldehyde CH amidation has been achieved with sulfonyl, aryl, and alkyl azides as the amine sources, and release of N2 as the only byproduct (see scheme). More importantly, this catalytic reaction proceeds in the absence of external oxidants or additives, under mild conditions, at neutral pH under air. This reaction represents a new avenue for practical intermolecular

  Ç  ħ激活：一个铑III催化的直接醛C  ħ酰胺化已经与磺酰基，芳基和烷基叠氮化作为胺源，以及N释放达到2作为唯一的副产物（参见方案）。更重要的是，该催化反应在温和条件下，在空气中性pH下，在没有外部氧化剂或添加剂的情况下进行。该反应代表了通过醛CH键活化形成实际分子间CN键的新途径。Cp * = 1,2,3,4,5-五甲基环戊二烯
• Copper-Catalyzed Transfer Hydrodeuteration of Aryl Alkenes with Quantitative Isotopomer Purity Analysis by Molecular Rotational Resonance Spectroscopy
  作者：Zoua Pa Vang、Albert Reyes、Reilly E. Sonstrom、Martin S. Holdren、Samantha E. Sloane、Isabella Y. Alansari、Justin L. Neill、Brooks H. Pate、Joseph R. Clark

  DOI：10.1021/jacs.1c00884

  日期：2021.5.26

  A copper-catalyzed alkene transfer hydrodeuteration reaction that selectively incorporates one hydrogen and one deuterium atom across an aryl alkene is described. The transfer hydrodeuteration protocol is selective across a variety of internal and terminal alkenes and is also demonstrated on an alkene-containing complex natural product analog. Beyond using 1H, 2H, and 13C NMR analysis to measure reaction

  描述了一种铜催化的烯烃转移加氢氘化反应，该反应选择性地将一个氢和一个氘原子结合到芳基烯烃上。转移加氢氘化协议对各种内部和末端烯烃具有选择性，并且还在含烯烃的复杂天然产物类似物上得到了证明。除了使用1 H、2 H 和13C NMR 分析测量反应选择性，六转移氢化氘化产物通过分子旋转共振 (MRR) 光谱分析。通过与高通量样品分析兼容的测量方法，进一步探索了 MRR 光谱在氘化学中同位素杂质分析中的应用。在第一步中，使用宽带啁啾脉冲傅立叶变换微波光谱仪分析反应化学中所有同位素变体的 MRR 光谱特征。有了签名，就可以创建测量脚本，使用商用腔增强 MRR 光谱仪对样品成分进行定量分析。使用该仪器的样品消耗量低于 10 毫克，分析时间约为 10 分钟 - 与宽带 MRR 光谱相比，两者都代表了数量级的减少。迄今为止，这些测量代表了转移加氢氘化反应中选择性的最精确的光谱测定，并确认在这种温和的协议下可以实现
• [EN] 3, 4 - SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS<br/>[FR] DÉRIVÉS DE PIPÉRIDINE 3,4-SUBSTITUÉE CONVENANT COMME INHIBITEURS DE LA RÉNINE
  申请人：MERCK FROSST CANADA LTD

  公开号：WO2009140769A1

  公开（公告）日：2009-11-26

  The present invention relates to 3,4-substituted piperidinyl - based renin inhibitor compounds bearing at 4-position lsoqumolone and having the Formula (I) : The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency.

  本发明涉及具有4-位lsoqumolone的3,4-取代哌啶基肾素抑制剂化合物，其化学式为（I）：该发明还涉及含有上述化合物的药物组合物，以及它们在治疗心血管事件和肾功能不全中的用途。
• Copper-Mediated Cross-Dehydrogenative Coupling of 2-Methylpyridine and 8-Methylquinoline with Methyl Ketones and Benzamides
  作者：Gadde Sathish Kumar、Joshua William Boyle、Ciputra Tejo、Philip Wai Hong Chan

  DOI：10.1002/asia.201501096

  日期：2016.2

  synthetic method to prepare (E)‐(pyridin‐2‐yl)enones and (E)‐(quinolin‐8‐yl)enones that relies on the respective copper(I)‐catalyzed formal cross‐dehydrogenative coupling (CDC) reaction of 2‐methylpyridine and 8‐methylquinoline with methyl ketones has been discovered. The mechanism was delineated to follow a pathway involving oxidation of the N‐heterocycle to its corresponding aldehyde adduct prior

  合成方法（E）-（吡啶-2-基）烯酮和（E）-（喹啉-8-基）烯酮依赖于各自的铜（I）催化的正式交叉脱氢偶联（CDC）反应发现了2-甲基吡啶和8-甲基喹啉与甲基酮的混合物。机理被描述为遵循在与甲基酮反应之前将N-杂环氧化成其相应的醛加合物的途径。铜介导的CDC策略在反应性上的多功能性和与底物有关的差异以其在合成N-（喹啉-8-基甲基）酰胺和N中的应用为例-（喹啉-8-甲基）苯胺加成物，将交叉偶联伙伴转换为苯甲酰胺或苯胺衍生物。